A Pilot Study to Evaluate Anti-Hepatitis C Virus Effect of Maraviroc in Patients Co-infected With Human Immunodeficiency Virus (HIV) and Hepatitis C
Phase of Trial: Phase IV
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Maraviroc (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms MAVERIC
- 30 Apr 2017 Planned End Date changed from 1 Jan 2018 to 1 Sep 2019.
- 30 Apr 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
- 30 Apr 2017 Status changed from not yet recruiting to recruiting.